Are you the developer of this app? Verify ownership to manage this listing.
The Center for Drug Evaluation and Research (CDER) assesses bioequivalence (BE) in generic drug applications primarily through a combination of regulatory requirements, scientific guidelines, and statistical criteria. The process ensures that a generic drug performs in the same manner as its reference listed drug (RLD).
Disclaimer: WebCatalog is not affiliated, associated, authorized, endorsed by or in any way officially connected to Rhizome. All product names, logos, and brands are property of their respective owners.
